Reader Response: Prevalence and Significance of Impaired Microvascular Tissue Reperfusion Despite Macrovascular Angiographic Reperfusion (No-Reflow)
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Ng et al.1 recently reported a 25% prevalence of hypoperfusion—a >15% reduction of cerebral blood flow (CBF) or cerebral blood volume (CBV) from the mirror region on CT perfusion imaging—within the 24-hour infarct window, despite complete anterior circulation recanalization (TICI 2c/3), which negatively affected functional outcome. These findings contrast with our earlier finding of 6% (2/33) hypoperfused infarcts, where the 24-hour arterial spin labeling (ASL)-CBF images were analyzed according to the Alberta Stroke Program Early CT Score (ASPECTS) template.2 We have reanalyzed our data set considering the entire middle cerebral arterial (MCA) territory, irrespective of ASPECTS. After excluding areas with confluent hemorrhagic transformation or parenchymal hematoma on the 24-hour MRI, consensus by 2 raters (kappa = 0.752) identified only 2 additional patients exhibiting patchy mild-to-moderate hypoperfusion with volumes too small to be reliably measured on ASL images, for a total prevalence of 4 of 33 patients (12%). After excluding patients with missing mRS (n = 2) or associated infarcts outside the MCA territory (n = 5), univariate analysis showed no significant association of “no-reflow” presence with a 3-month mRS of 0–1 or 0–2. A multivariate analysis was precluded by low occurrence of no-reflow. Taken together with this article and another recent report,3 the prevalence of no-reflow after recanalized MCA stroke appears to stand ∼15–20%, depending on the perfusion modality used, and often involves small areas. The true impact on clinical outcome remains unclear.3
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received November 21, 2022.
- Accepted in final form November 21, 2022.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.